Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Previously, we detected circulating tumor DNA that contained two EGFR mutations (p.L858R and exon19 del) in plasma of patients with late-stage non–small-cell lung carcinoma (NSCLC) using the electric field–induced release and measurement (EFIRM) platform. Our aim was to determine whether EFIRM techn...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Mol Diagn
Autores principales: Wei, Fang, Strom, Charles M., Cheng, Jordan, Lin, Chien-Chung, Hsu, Ching-Yun, Soo Hoo, Guy W., Chia, David, Kim, Yong, Li, Feng, Elashoff, David, Grognan, Tristan, Tu, Michael, Liao, Wei, Xian, Rena, Grody, Wayne W., Su, Wu-Chou, Wong, David T.W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Investigative Pathology 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6198245/
https://ncbi.nlm.nih.gov/pubmed/30309763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2018.06.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares